Mortality outcomes stratified by prevalent HF status are shown in Supplemental Table S13, with most proteins showing consistency of effects in both groups, but with some proteins (Gal-9, KIM1, TIMP1, SPINT2, PARTP-1) showing stronger effects in individuals without prevalent HF. This evidence concerns the gene LGALS9 and hydrops fetalis.